Le groupe Menarini annonce une demande d’autorisation de mise sur le marché de la délafloxacine
Le groupe Menarini a annoncé aujourd »hui qu »il a déposé, le 6 mars 2017, une demande d »autorisation de mise sur le…
Popular Posts...
-
-
Tabuk Pharmaceuticals Signs a Commercial Agreement with Renapharma AB
-
Marler Clark: Managing Partner Bill Marler travels to South Africa to address Food Focus Listeria Conference
-
Daiichi Sankyo Presents Phase 1 Data for EZH1/2 Dual Inhibitor DS-3201 in Patients with Non-Hodgkin Lymphomas at the 59th Annual Meeting of the American Society of Hematology
-
Exscientia Initiates Sixth AI Drug Discovery Partnership
-
MobileODT and Partners to Launch First Wide-Scale Deployment of AI screening for Cervical Cancer
-
Zentiva Strengthens European Generic Footprint With Prague Manufacturing Site Investment
-
CORRECTION: CBD Market Could Outpace Entire Marijuana Market
-
HS-UK Look Forward to an Exciting Optrafair 2019
-
Use and benefits of Cbd oil